Literature DB >> 33416494

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.

David W Hawman1, Kimberly Meade-White1, Shanna Leventhal1, Friederike Feldmann1, Atsushi Okumura1, Brian Smith2, Dana Scott3, Heinz Feldmann1.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne febrile illness with wide geographic distribution. CCHF is caused by infection with the Crimean-Congo hemorrhagic fever virus (CCHFV) and case fatality rates can be as high as 30%. Despite causing severe disease in humans, our understanding of the host and viral determinants of CCHFV pathogenesis are limited. A major limitation in the investigation of CCHF has been the lack of suitable small animal models. Wild-type mice are resistant to clinical isolates of CCHFV and consequently, mice must be deficient in type I interferon responses to study the more severe aspects of CCHFV. We report here a mouse-adapted variant of CCHFV that recapitulates in adult, immunocompetent mice the severe CCHF observed in humans. This mouse-adapted variant of CCHFV significantly improves our ability to study host and viral determinants of CCHFV-induced disease in a highly tractable mouse model.

Entities:  

Keywords:  CCHFV; Crimean-Congo hemorrhagic fever virus; immunology; infectious disease; inflammation; microbiology; mouse model; virus

Mesh:

Substances:

Year:  2021        PMID: 33416494      PMCID: PMC7811403          DOI: 10.7554/eLife.63906

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  60 in total

1.  Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases.

Authors:  Glenn C Capodagli; Michelle K Deaton; Erica A Baker; Ryan J Lumpkin; Scott D Pegan
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

2.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques.

Authors:  David W Hawman; Elaine Haddock; Kimberly Meade-White; Glenn Nardone; Friederike Feldmann; Patrick W Hanley; Jamie Lovaglio; Dana Scott; Takashi Komeno; Nozomi Nakajima; Yousuke Furuta; Brian B Gowen; Heinz Feldmann
Journal:  Antiviral Res       Date:  2020-07-06       Impact factor: 5.970

4.  First records of adult Hyalomma marginatum and H. rufipes ticks (Acari: Ixodidae) in Sweden.

Authors:  Giulio Grandi; Lidia Chitimia-Dobler; Phimphanit Choklikitumnuey; Christina Strube; Andrea Springer; Ann Albihn; Thomas G T Jaenson; Anna Omazic
Journal:  Ticks Tick Borne Dis       Date:  2020-01-30       Impact factor: 3.744

5.  Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.

Authors:  Ida Andersson; Linda Bladh; Mehrdad Mousavi-Jazi; Karl-Eric Magnusson; Ake Lundkvist; Otto Haller; Ali Mirazimi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.

Authors:  Lisa Oestereich; Toni Rieger; Melanie Neumann; Christian Bernreuther; Maria Lehmann; Susanne Krasemann; Stephanie Wurr; Petra Emmerich; Xavier de Lamballerie; Stephan Ölschläger; Stephan Günther
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

7.  Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins.

Authors:  Veronica V Rezelj; Ping Li; Vidyanath Chaudhary; Richard M Elliott; Dong-Yan Jin; Benjamin Brennan
Journal:  mSphere       Date:  2017-06-28       Impact factor: 4.389

8.  A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.

Authors:  Aura R Garrison; Charles J Shoemaker; Joseph W Golden; Collin J Fitzpatrick; John J Suschak; Michelle J Richards; Catherine V Badger; Carolyn M Six; Jacqueline D Martin; Drew Hannaman; Marko Zivcec; Eric Bergeron; Jeffrey W Koehler; Connie S Schmaljohn
Journal:  PLoS Negl Trop Dis       Date:  2017-09-18

9.  Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses.

Authors:  Natalia Frias-Staheli; Nadia V Giannakopoulos; Marjolein Kikkert; Shannon L Taylor; Anne Bridgen; Jason Paragas; Juergen A Richt; Raymond R Rowland; Connie S Schmaljohn; Deborah J Lenschow; Eric J Snijder; Adolfo García-Sastre; Herbert Whiting Virgin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

10.  The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity.

Authors:  Natalia Freitas; Margot Enguehard; Solène Denolly; Camille Levy; Gregory Neveu; Solène Lerolle; Stephanie Devignot; Friedemann Weber; Eric Bergeron; Vincent Legros; François-Loïc Cosset
Journal:  PLoS Pathog       Date:  2020-09-21       Impact factor: 6.823

View more
  8 in total

1.  In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.

Authors:  Akinyemi Ademola Omoniyi; Samuel Sunday Adebisi; Sunday Abraham Musa; James Oliver Nzalak; Zainab Mahmood Bauchi; Kerkebe William Bako; Oluwasegun Davis Olatomide; Richard Zachariah; Jens Randel Nyengaard
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 2.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

Review 3.  Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Authors:  Solène Lerolle; Natalia Freitas; François-Loïc Cosset; Vincent Legros
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

4.  T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice.

Authors:  David W Hawman; Kimberly Meade-White; Shanna Leventhal; Aaron Carmody; Elaine Haddock; Kim Hasenkrug; Heinz Feldmann
Journal:  Microorganisms       Date:  2021-01-29

Review 5.  Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection.

Authors:  Jiawen Sun; Yuan-Qin Min; Yunjie Li; Xiulian Sun; Fei Deng; Hualin Wang; Yun-Jia Ning
Journal:  Front Microbiol       Date:  2022-01-11       Impact factor: 5.640

6.  Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19).

Authors:  Hamid Behrouj; Omid Vakili; Adel Sadeghdoust; Neda Aligolighasemabadi; Parnian Khalili; Mozhdeh Zamani; Pooneh Mokarram
Journal:  Biochem Biophys Rep       Date:  2022-04-21

Review 7.  Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response.

Authors:  Bryce M Warner
Journal:  Pathogens       Date:  2021-03-01

Review 8.  Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies.

Authors:  Shiyu Dai; Fei Deng; Hualin Wang; Yunjia Ning
Journal:  Viruses       Date:  2021-06-22       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.